Cargando…

Characteristic of K3 (CpG-ODN) as a Transcutaneous Vaccine Formulation Adjuvant

Transcutaneous immunization (TCI) is easy to use, minimally invasive, and has excellent efficacy in vaccines against infections. We focused on toll-like receptor (TLR) ligands as applicable adjuvants for transcutaneous formulations and characterized immune responses. TCI was performed using poke-and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Sayami, Hirobe, Sachiko, Kawakita, Takuto, Saito, Mio, Quan, Ying-Shu, Kamiyama, Fumio, Ishii, Ken J., Nagao, Mizuho, Fujisawa, Takao, Tachibana, Masashi, Okada, Naoki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151019/ https://www.ncbi.nlm.nih.gov/pubmed/32183437 http://dx.doi.org/10.3390/pharmaceutics12030267

Ejemplares similares

Adjuvant Activity of CpG-Oligonucleotide Administered Transcutaneously in Combination with Vaccination Using a Self-Dissolving Microneedle Patch in Mice
por: Hirobe, Sachiko, et al.
Publicado: (2021)

Transcutaneous Administration of Imiquimod Promotes T and B Cell Differentiation into Effector Cells or Plasma Cells
por: Hirobe, Sachiko, et al.
Publicado: (2022)

Development of Novel Faster-Dissolving Microneedle Patches for Transcutaneous Vaccine Delivery
por: Ono, Akihiko, et al.
Publicado: (2017)

Correction: Development of Novel Faster-Dissolving Microneedle Patches for Transcutaneous Vaccine Delivery. Pharmaceutics, 2017, 9(3), 27
por: Ono, Akihiko, et al.
Publicado: (2017)

Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model
por: Golali, Ensieh, et al.
Publicado: (2012)

The effect of CpG-ODN on antigen presenting cells of the foal
por: Flaminio, M Julia BF, et al.
Publicado: (2007)

Effect of CpG ODN on monocytic myeloid derived suppressor cells
por: Shirota, Hidekazu, et al.
Publicado: (2012)

TRAIL is involved in CpG ODN-mediated anti-apoptotic signals
por: LIM, EUN-JUNG, et al.
Publicado: (2011)

Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial
por: Ursu, Renata, et al.
Publicado: (2015)

Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria
por: Hirobe, Sachiko, et al.
Publicado: (2012)

Limited Effect of CpG ODN in Preventing Type 1 Diabetes in NOD Mice
por: Lee, Byong Jun, et al.
Publicado: (2005)

Toll-like receptor 9 interaction with CpG ODN – An in silico analysis approach
por: Zhou, Wei, et al.
Publicado: (2013)

Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanorings
por: Gungor, Bilgi, et al.
Publicado: (2014)

Identification of Differentially Expressed lncRNAs in a CpG ODN-Activated Macrophage
por: Zheng, Ying, et al.
Publicado: (2020)

The Role of Liposomal CpG ODN on the Course of L. major Infection in BALB/C Mice
por: Hejazi, H, et al.
Publicado: (2010)

Increased Sensitivity to Chemotherapy Induced by CpG-ODN Treatment Is Mediated by microRNA Modulation
por: De Cecco, Loris, et al.
Publicado: (2013)

CpG-ODN Class C Mediated Immunostimulation in Rabbit Model of Trypanosoma evansi Infection
por: Kumar, Parveen, et al.
Publicado: (2015)

Pleiotropic action of CpG-ODN on endothelium and macrophages attenuates angiogenesis through distinct pathways
por: Wu, Jiahui, et al.
Publicado: (2016)

Radiosensitization by CpG ODN7909 in an epidermoid laryngeal carcinoma Hep-2 cell line
por: Wang, Shu, et al.
Publicado: (2017)

Treatment with phosphodiester CpG-ODN ameliorates atopic dermatitis by enhancing TGF-β signaling
por: Ham, Won-Kook, et al.
Publicado: (2021)

TLR9-mediated ARF6 activation is involved in advancing CpG ODN cellular uptake
por: Wu, Jing-Yiing, et al.
Publicado: (2012)

High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors
por: Sommariva, Michele, et al.
Publicado: (2013)

Preparation and characterization of PLGA nanospheres loaded with inactivated influenza virus, CpG-ODN and Quillaja saponin
por: Mohajer, Maryam, et al.
Publicado: (2014)

In Ovo Administration of CpG ODN Induces Expression of Immune Response Genes in Neonatal Chicken Spleen
por: Sajewicz-Krukowska, Joanna, et al.
Publicado: (2017)

Frontiers of transcutaneous vaccination systems: Novel technologies and devices for vaccine delivery
por: Matsuo, Kazuhiko, et al.
Publicado: (2013)

CpG-ODN and MPLA Prevent Mortality in a Murine Model of Post-Hemorrhage-Staphyloccocus aureus Pneumonia
por: Roquilly, Antoine, et al.
Publicado: (2010)

Plasmacytoid Dendritic Cell Response to CpG ODN Correlates with CXCL16 Expression and Is Inhibited by ox-LDL
por: Gursel, Mayda, et al.
Publicado: (2013)

CpG-ODN Shapes Alum Adjuvant Activity Signaling via MyD88 and IL-10
por: Mirotti, Luciana, et al.
Publicado: (2017)

CpG-ODN Facilitates Effective Intratracheal Immunization and Recall of Memory against Neoantigen-Expressing Alveolar Cells
por: Riehn, Mathias, et al.
Publicado: (2017)

Immunogenicity evaluation of the HIV-1 Tat containing polyepitope DNA vaccine adjuvanted with CpG-ODNs in mice
por: Ollah Jazaeri, Ehsan, et al.
Publicado: (2021)

CpG ODN and ISCOMATRIX Adjuvant: A Synergistic Adjuvant Combination Inducing Strong T-Cell IFN-γ Responses
por: McCluskie, Michael J., et al.
Publicado: (2013)

The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide
por: Lai, Chunhui, et al.
Publicado: (2018)

Induction of Robust Immune Responses by CpG-ODN-Loaded Hollow Polymeric Nanoparticles for Antiviral and Vaccine Applications in Chickens
por: Lin, Shu-Yi, et al.
Publicado: (2020)

Activation of CpG-ODN-Induced TLR9 Signaling Inhibited by Interleukin-37 in U937 Human Macrophages
por: Kim, Seong-Kyu, et al.
Publicado: (2021)

CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV
por: Zhao, Huajun, et al.
Publicado: (2022)

CpG-ODN induced antimicrobial immunity in neonatal chicks involves a substantial shift in serum metabolic profiles
por: Goonewardene, Kalhari Bandara, et al.
Publicado: (2021)

Control of A/D type CpG-ODN aggregates to a suitable size for induction of strong immunostimulant activity
por: Matsuda, Miyu, et al.
Publicado: (2023)

The Effects of Chimeric Antigen Receptor (CAR) Hinge Domain Post-Translational Modifications on CAR-T Cell Activity
por: Hirobe, Sachiko, et al.
Publicado: (2022)

Binding and Efficacy of Anti-Robo4 CAR-T Cells against Solid Tumors
por: Hirobe, Sachiko, et al.
Publicado: (2022)

Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores
por: Hessenberger, Michael, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l1quopiqjuhpo8jot52773rfe1